Johnson & Johnson
Revenue Breakdown
| Fiscal Year | Consumer Health | Pharmaceutical / Innovative Medicine | Medical Devices / MedTech |
|---|---|---|---|
| FY2021 | $14.64B | $52.08B | $27.06B |
| FY2022 | $14.95B | $52.56B | $27.43B |
| FY2023 | $0 | $54.76B | $30.40B |
| FY2024 | $0 | $56.96B | $31.86B |
| FY2025 | $0 | $60.40B | $33.79B |